AERI insider filings
AERIE PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-11-21. Screen AERI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AERI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AERIE PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-11-21 | 4 | McHugh Julie — Director | Disposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-21 | 4 | McDonnell Peter J — Director | Disposition to issuer (D): 7,995 @ $15.25 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-21 | 4 | Kopczynski Casey C. — Chief Scientific Officer | Disposition to issuer (D): 280,244 @ $15.25 · Disposition to issuer (D): 25,000 (derivative) @ $12.10 · Disposition to issuer (D): 65,941 (derivative) @ $6.45 | EDGAR |
| 2022-11-21 | 4 | Lang Peter Frederick — Chief Financial Officer | Disposition to issuer (D): 46,297 @ $15.25 · Disposition to issuer (D): 160,551 (derivative) @ $6.45 | EDGAR |
| 2022-11-21 | 4 | LaRocca John — General Counsel | Disposition to issuer (D): 53,585 @ $15.25 · Disposition to issuer (D): 65,941 (derivative) @ $6.45 | EDGAR |
| 2022-11-21 | 4 | du Toit Michael — Director | Disposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-21 | 4 | Croarkin Richard — Director | Disposition to issuer (D): 16,095 @ $15.25 · Disposition to issuer (D): 25,000 (derivative) @ $4.81 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-21 | 4 | Calabrese Jeffrey — Vice President of Finance | Disposition to issuer (D): 18,585 @ $15.25 · Disposition to issuer (D): 6,257 (derivative) @ $4.23 · Disposition to issuer (D): 20,774 (derivative) @ $6.89 | EDGAR |
| 2022-11-21 | 4 | KANNAN RAJ — Chief Executive Officer, Director | Disposition to issuer (D): 215,783 @ $15.25 · Disposition to issuer (D): 387,169 (derivative) @ $7.14 · Disposition to issuer (D): 197,239 (derivative) @ $6.45 | EDGAR |
| 2022-11-21 | 4 | MCGRAW BENJAMIN F III — Director | Disposition to issuer (D): 41,984 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 102,412 (derivative) @ $3.66 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-21 | 4 | GRYSKA DAVID W — Director | Disposition to issuer (D): 11,495 @ $15.25 · Disposition to issuer (D): 1,996 @ $15.25 · Disposition to issuer (D): 7,800 (derivative) @ $1.98 · Disposition to issuer (D): 16,854 (derivative) @ $9.14 | EDGAR |
| 2022-11-03 | 4 | Calabrese Jeffrey — Vice President of Finance | Tax withholding (F): 179 @ $15.22 | EDGAR |
| 2022-08-16 | 4 | LaRocca John — General Counsel | Tax withholding (F): 771 @ $11.57 | EDGAR |
| 2022-08-16 | 4 | Calabrese Jeffrey — Vice President of Finance | Tax withholding (F): 265 @ $11.57 | EDGAR |
| 2022-07-13 | 4 | Calabrese Jeffrey — Vice President of Finance | Tax withholding (F): 266 @ $8.36 | EDGAR |
| 2022-07-06 | 4 | Calabrese Jeffrey — Vice President of Finance | Grant/award (A): 11,276 @ $0 · Grant/award (A): 20,774 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | McHugh Julie — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | McDonnell Peter J — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | du Toit Michael — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Croarkin Richard — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | MCGRAW BENJAMIN F III — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 6,245 @ $0 · Grant/award (A): 16,854 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | Kopczynski Casey C. — Chief Scientific Officer | Grant/award (A): 19,015 @ $0 · Grant/award (A): 65,941 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | LaRocca John — General Counsel | Grant/award (A): 19,015 @ $0 · Grant/award (A): 65,941 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | KANNAN RAJ — Chief Executive Officer, Director | Grant/award (A): 197,239 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | Lang Peter Frederick — Chief Financial Officer | Grant/award (A): 46,297 @ $0 · Grant/award (A): 160,551 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | MCGRAW BENJAMIN F III — Interim Executive Chair, Director | Tax withholding (F): 10,324 @ $8.30 | EDGAR |
| 2022-02-23 | 4 | LaRocca John — General Counsel | Tax withholding (F): 1,973 @ $6 | EDGAR |
| 2022-02-09 | 4 | Kopczynski Casey C. — Chief Scientific Officer | Tax withholding (F): 701 @ $7.24 · Tax withholding (F): 700 @ $7.33 | EDGAR |
| 2022-02-09 | 4 | LaRocca John — General Counsel | Tax withholding (F): 768 @ $7.24 | EDGAR |
| 2022-02-09 | 4 | MITRO THOMAS A — President and COO | Tax withholding (F): 1,310 @ $7.24 · Tax withholding (F): 1,111 @ $7.33 | EDGAR |
| 2022-02-08 | 4 | Hollander David — Chief R&D Officer | Tax withholding (F): 927 @ $7.05 | EDGAR |
| 2022-02-08 | 4 | Kopczynski Casey C. — Chief Scientific Officer | Tax withholding (F): 963 @ $7.05 · Tax withholding (F): 876 @ $7.05 | EDGAR |
| 2022-02-08 | 4 | LaRocca John — General Counsel | Tax withholding (F): 1,206 @ $7.05 · Tax withholding (F): 384 @ $7.05 | EDGAR |
| 2022-02-08 | 4 | MITRO THOMAS A — President and COO | Tax withholding (F): 1,435 @ $7.05 · Tax withholding (F): 1,435 @ $7.05 | EDGAR |
| 2022-02-01 | 4 | MCGINLEY KATHLEEN — CHRO & VP, Corp Services | Tax withholding (F): 878 @ $6.92 | EDGAR |
| 2021-12-22 | 4 | KANNAN RAJ — Chief Executive Officer, Director | Grant/award (A): 215,783 @ $0 · Grant/award (A): 387,169 (derivative) @ $0 | EDGAR |
| 2021-11-15 | 4 | Hollander David — Chief R&D Officer | Tax withholding (F): 2,162 @ $12.06 | EDGAR |
| 2021-09-22 | 4 | MCGRAW BENJAMIN F III — Interim Executive Chair, Director | Grant/award (A): 34,513 @ $0 · Grant/award (A): 102,412 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | LaRocca John — General Counsel | Tax withholding (F): 765 @ $14.70 | EDGAR |
| 2021-08-17 | 4 | Staten Christopher — Interim CFO | Tax withholding (F): 877 @ $14.70 | EDGAR |
| 2021-06-21 | 4 | McHugh Julie — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | du Toit Michael — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Cagle Gerald D. — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | McDonnell Peter J — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Croarkin Richard — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | MCGRAW BENJAMIN F III — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 7,800 (derivative) @ $0 | EDGAR |
| 2021-02-25 | 4 | MITRO THOMAS A — President and COO | Tax withholding (F): 763 @ $15.66 | EDGAR |
| 2021-02-25 | 4 | ANIDO VICENTE JR — Chief Executive Officer, Director | Tax withholding (F): 1,700 @ $15.66 | EDGAR |
Recent 8-K events — AERIE PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-11-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-11-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AERI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs